Search

Your search keyword '"Garcia-Tejedor, Amparo"' showing total 27 results
Start Over Author "Garcia-Tejedor, Amparo"
27 results on '"Garcia-Tejedor, Amparo"'

1. Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival—a propensity score cohort study

Author

Fernandez-Gonzalez, Sergi, Falo, Catalina, Pla, Maria J., Campos, Miriam, Ortega-Exposito, Carlos, Ortega, Raul, Vicente, Maria, Petit, Ana, Bosch-Schips, Jan, Bajen, Maria Teresa, Reyes, Gabriel, Martínez, Evelyn, González-Viguera, Javier, Peñafiel, Judith, Stradella, Agostina, Pernas, Sonia, Ponce, Jordi, and Garcia-Tejedor, Amparo

Published
2024
Full Text
View/download PDF

2. Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact

Author

Garcia-Tejedor, Amparo, Falo, Catalina, Fernandez-Gonzalez, Sergi, Laplana, Maria, Gil-Gil, Miguel, Soler-Monso, Teresa, Martinez-Perez, Evelyn, Calvo, Iris, Calpelo, Hugo, Bajen, Maria-Teresa, Benitez, Ana, Ortega, Raul, Petit, Anna, Guma, Anna, Campos, Miriam, Stradella, Agostina, Lopez-Ojeda, Ana, Ponce, Jordi, Pla, Maria J., and Pernas, Sonia

Published
2023
Full Text
View/download PDF

5. Comparing the effects of alcohol sclerotherapy with those of surgery on anti-Müllerian hormone and ovarian reserve after endometrioma treatment. A prospective multicenter pilot cohort study

Author

Martinez-Garcia, Jose M., Candas, Beatriz, Suarez-Salvador, Elena, Gomez, Maria, Merino, Elisabet, Castellarnau, Marta, Carreras, Manuel, Carrarach, Marta, Subirats, Neus, Gonzalez, Santiago, Fernández-Montolí, Eulalia, Ponce, Jordi, and Garcia-Tejedor, Amparo

Published
2021
Full Text
View/download PDF

6. Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?

Author

Garcia-Tejedor, Amparo, Fernandez-Gonzalez, Sergi, Ortega, Raul, Gil-Gil, Miguel, Perez-Montero, Hector, Fernandez-Montolí, Eulalia, Stradella, Agostina, Recalde, Sabela, Soler, Teresa, Petit, Anna, Bajen, Maria Teresa, Benitez, Ana, Guma, Anna, Campos, Miriam, Pla, Maria J., Martinez, Evelyn, Laplana, Maria, Pernas, Sonia, Perez-Sildekova, Diana, Catala, Isabel, Ponce, Jordi, and Falo, Catalina

Published
2021
Full Text
View/download PDF

7. Ethanol Sclerotherapy versus Laparoscopic Surgery for Endometrioma Treatment: A Prospective, Multicenter, Cohort Pilot Study

Author

Garcia-Tejedor, Amparo, Martinez-Garcia, Jose M., Candas, Beatriz, Suarez, Elena, Mañalich, Laura, Gomez, Maria, Merino, Elisabet, Castellarnau, Marta, Regueiro, Purificacion, Carreras, Manuel, Martinez-Franco, Eva, Carrarrach, Marta, Subirats, Neus, Barbera, Judith, Gonzalez, Santiago, Climent, Maite, Fernández-Montolí, Eulalia, and Ponce, Jordi

Published
2020
Full Text
View/download PDF

8. Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)

Author

Garcia-Tejedor, Amparo, primary, Ortega-Exposito, Carlos, additional, Salinas, Sira, additional, Luzardo-González, Ana, additional, Falo, Catalina, additional, Martinez-Pérez, Evelyn, additional, Pérez-Montero, Héctor, additional, Soler-Monsó, M. Teresa, additional, Bajen, Maria-Teresa, additional, Benitez, Ana, additional, Ortega, Raul, additional, Petit, Anna, additional, Guma, Anna, additional, Campos, Miriam, additional, Plà, Maria J., additional, Pernas, Sonia, additional, Peñafiel, Judith, additional, Yeste, Carlos, additional, Gil-Gil, Miguel, additional, Guedea, Ferran, additional, Ponce, Jordi, additional, and Laplana, Maria, additional

Published
2023
Full Text
View/download PDF

9. The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures

Author

Fernandez-Gonzalez, Sergi, Falo, Catalina, Pla, Maria Jesus, Pernas, Sonia, Bajen, Maite, Soler, Teresa, Ortega, Raul, Quetglas, Cecilia, Perez-Martin, Xavier, Fernandez Montoli, Maria Eulalia, Campos, Miriam, Varela-Rodriguez, Mar, Ponce, Jordi, and Garcia-Tejedor, Amparo

Published
2018
Full Text
View/download PDF

12. Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/ HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.

Author

Garcia-Tejedor, Amparo, primary, Fernandez-Gonzalez, Sergi, additional, Laplana, Maria, additional, Gil-Gil, Miguel, additional, Martinez, Evelyn, additional, Calvo, Iris, additional, Calpelo, Hugo, additional, Ortega, Raul, additional, Petit, Anna, additional, Guma, Anna, additional, Campos, Miriam, additional, Stradella, Agostina, additional, and López-Ojeda, Ana, additional

Published
2023
Full Text
View/download PDF

14. Abstract P1-08-26: Morphologic characterization of tumor-infiltrating lymphocytes and its relation with pathological response in a series of breast cancer patients treated with primary chemotherapy

Author

Falo, Catalina, primary, Azcarate, Juan, additional, Petit, Ana, additional, Vethencourt, Andrea, additional, Gonzalez, Sergi Fernandez, additional, Garcia-Tejedor, Amparo, additional, Vazquez, Silvia, additional, Perez, Hector, additional, Laplana, Maria, additional, Taco, Charo, additional, Guerra, Esther, additional, Guma, Anna, additional, Ortega, Raul, additional, Stradella, Agostina, additional, Recalde, Sabela, additional, Fernandez-Ortega, Adela, additional, Villanueva, Rafael, additional, Perez, F Javier, additional, Pla, M Jesus, additional, Campos, Miriam, additional, Perez, Diana, additional, Fernandez-Montoliu, Eulalia, additional, Obadia, Veronica, additional, Cejuela, Monica, additional, Gil-Gil, Miguel, additional, Pernas, Sonia, additional, Varela, Mar, additional, and Soler-Monzo, Teresa, additional

Published
2022
Full Text
View/download PDF

16. Assessment of Tumor Cell Death After Percutaneous Ultrasound– Guided Radiofrequency Ablation of Breast Carcinoma: A Prospective Study

Author

Guma, Anna, primary, Soler, Teresa, additional, Chappuis, César G., additional, Valdivielso, Alazne, additional, Petit, Anna, additional, Pla, Maria J., additional, Falo, Catalina, additional, Pernas, Sònia, additional, Ortega, Raúl, additional, Vicente, María, additional, Pérez, Laia, additional, Fernandez-Montoli, Eulalia, additional, Campos, Miriam, additional, Burdio, Fernando, additional, Ponce, Jordi, additional, Calvo, Nahum, additional, and Garcia-Tejedor, Amparo, additional

Published
2021
Full Text
View/download PDF

17. Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?

Author

Garcia-Tejedor, Amparo, primary, Fernandez-Gonzalez, Sergi, additional, Ortega, Raul, additional, Gil-Gil, Miguel, additional, Perez-Montero, Hector, additional, Fernandez-Montolí, Eulalia, additional, Stradella, Agostina, additional, Recalde, Sabela, additional, Soler, Teresa, additional, Petit, Anna, additional, Bajen, Maria Teresa, additional, Benitez, Ana, additional, Guma, Anna, additional, Campos, Miriam, additional, Pla, Maria J., additional, Martinez, Evelyn, additional, Laplana, Maria, additional, Pernas, Sonia, additional, Perez-Sildekova, Diana, additional, Catala, Isabel, additional, Ponce, Jordi, additional, and Falo, Catalina, additional

Published
2020
Full Text
View/download PDF

18. Predictive factors for omitting lymphadenectomy in patients with node‐positive breast cancer treated with neo‐adjuvant systemic therapy

Author

Fernandez‐Gonzalez, Sergi, primary, Falo, Catalina, additional, Pla, Maria J., additional, Verdaguer, Paula, additional, Nuñez, Diana, additional, Guma, Anna, additional, Soler, Teresa, additional, Vethencourt, Andrea, additional, Vázquez, Silvia, additional, Fernandez‐Montoli, Maria Eulalia, additional, Campos, Miriam, additional, Pernas, Sonia, additional, Gil, Miguel, additional, Ponce, Jordi, additional, and Garcia‐Tejedor, Amparo, additional

Published
2020
Full Text
View/download PDF

20. Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution

Author

Pernas, Sonia, primary, Petit, Anna, additional, Climent, Fina, additional, Paré, Laia, additional, Perez-Martin, J., additional, Ventura, Luz, additional, Bergamino, Milana, additional, Galván, Patricia, additional, Falo, Catalina, additional, Morilla, Idoia, additional, Fernandez-Ortega, Adela, additional, Stradella, Agostina, additional, Rey, Montse, additional, Garcia-Tejedor, Amparo, additional, Gil-Gil, Miguel, additional, and Prat, Aleix, additional

Published
2019
Full Text
View/download PDF

21. PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution

Author

Pernas, Sonia, primary, Petit, Anna, additional, Climent, Fina, additional, Paré, Laia, additional, Perez-Martin, J., additional, Ventura, Luz, additional, Bergamino, Milana, additional, Galván, Patricia, additional, Falo, Catalina, additional, Morilla, Idoia, additional, Fernandez-Ortega, Adela, additional, Stradella, Agostina, additional, Rey, Montse, additional, Garcia-Tejedor, Amparo, additional, Gil-Gil, Miguel, additional, and Prat, Aleix, additional

Published
2019
Full Text
View/download PDF

26. Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease.

Author

Falo C, Azcarate J, Fernandez-Gonzalez S, Perez X, Petit A, Perez H, Vethencourt A, Vazquez S, Laplana M, Ales M, Stradella A, Fullana B, Pla MJ, Gumà A, Ortega R, Varela M, Pérez D, Ponton JL, Cobo S, Benitez A, Campos M, Fernández A, Villanueva R, Obadia V, Recalde S, Soler-Monsó T, Lopez-Ojeda A, Martinez E, Ponce J, Pernas S, Gil-Gil M, and Garcia-Tejedor A

Abstract

Introduction : Neoadjuvant chemotherapy in breast cancer offers the possibility to facilitate breast and axillary surgery; it is a test of chemosensibility in vivo with significant prognostic value and may be used to tailor adjuvant treatment according to the response. Material and Methods : A retrospective single-institution cohort of 482 stage II and III breast cancer patients treated with neoadjuvant chemotherapy based on anthracycline and taxans, plus antiHEr2 in Her2-positive cases, was studied. Survival was calculated at 5 and 10 years. Kaplan-Meier curves with a log-rank test were calculated for differences according to age, BRCA status, menopausal status, TNM, pathological and molecular surrogate subtype, 20% TIL cut-off, surgical procedure, response to chemotherapy and the presence of vascular invasion. Results : The pCR rate was 25.3% and was greater in HER2 (51.3%) and TNBC (31.7%) and in BRCA carriers (41.9%). The factors independently related to patient survival were pathology and molecular surrogate subtype, type of surgery, response to NACT and vascular invasion. BRCA status was a protective prognostic factor without reaching statistical significance, with an HR 0.5 (95%CI 0.1-1.4). Mastectomy presented a double risk of distant recurrence compared to breast-conservative surgery (BCS), supporting BCS as a safe option after NACT. After a mean follow-up of 126 (SD 43) months, luminal tumors presented a substantial difference in survival rates calculated at 5 or 10 years (81.2% compared to 74.7%), whereas that for TNBC was 75.3 and 73.5, respectively. The greatest difference was seen according to the response in patients with pCR, who exhibited a 10 years DDFS of 95.5% vs. 72.4% for those patients without pCR, p < 0001. This difference was especially meaningful in TNBC: the 10 years DDFS according to an RCB of 0 to 3 was 100%, 80.6%, 69% and 49.2%, respectively, p < 0001. Patients with a particularly poor prognosis were those with lobular carcinomas, with a 10 years DDFS of 42.9% vs. 79.7% for ductal carcinomas, p = 0.001, and patients with vascular invasion at the surgical specimen, with a 10 years DDFS of 59.2% vs. 83.6% for those patients without vascular invasion, p < 0.001. Remarkably, BRCA carriers presented a longer survival, with an estimated 10 years DDFS of 89.6% vs. 77.2% for non-carriers, p = 0.054. Conclusions : Long-term outcomes after neoadjuvant chemotherapy can help patients and clinicians make well-informed decisions.

Published
2024
Full Text
View/download PDF

27. Risk factors for vertical transmission of hepatitis C virus: a single center experience with 710 HCV-infected mothers.

Author

Garcia-Tejedor A, Maiques-Montesinos V, Diago-Almela VJ, Pereda-Perez A, Alberola-Cuñat V, López-Hontangas JL, Perales-Puchalt A, and Perales A

Subjects
Adult, Coinfection complications, Episiotomy adverse effects, Female, Fetal Monitoring, Hepacivirus, Hepatitis C complications, Humans, Parturition, Pregnancy, Retrospective Studies, Risk Factors, Viral Load, HIV Infections complications, Hepatitis C transmission, Infectious Disease Transmission, Vertical statistics & numerical data
Abstract

Objective: The aim of this study was to analyze the risk factors on the perinatal transmission of hepatitis C virus (HCV)., Study Design: A retrospective cohort study with 711 infants born to 710 HCV-infected mothers was conducted at the Hospital La Fe, in Valencia, Spain, from 1986 to 2011. As potential risk factors for transmission we analyzed: maternal age, mode of acquisition of HCV infection, HIV co-infection, antiretroviral treatment against HIV, CD4 cell count, HIV and HCV viral load, liver enzyme levels during pregnancy, smoking habit, gestational age, intrapartum invasive procedures, length of rupture of membranes, length of labor, mode of delivery, episiotomy, birth weight, newborn gender and type of feeding., Results: Overall perinatal HCV transmission rate was 2.4%. The significant risk factors related with HCV transmission were maternal virus load >615copies/mL (OR 9.3 [95% CI 1.11-78.72]), intrapartum invasive procedures (OR 10.1 [95% CI 2.6-39.02]) and episiotomy (OR 4.2 [95% CI 1.2-14.16]). HIV co-infection and newborn female were near significance (p=0.081 and 0.075, respectively)., Conclusions: Invasive procedures as fetal scalp blood sampling or internal electrode and episiotomy increase vertical transmission of HCV, especially in patients with positive HCV RNA virus load at delivery., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results